293 related articles for article (PubMed ID: 29903985)
21. FUBP1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma.
Zhang Y; Chen J; Zhou N; Lu Y; Lu J; Xing X; Chen H; Zhang X
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649780
[TBL] [Abstract][Full Text] [Related]
22. CBX3 promotes breast cancer progression and high level of CBX3 predicts poor prognosis in patients.
Yang K; Wang YL; Zhu Z; Cao XH; Liang MX; Xu D; Fei YJ; Yang SY; Zhou HL; Tang JH
Neoplasma; 2023 Feb; 70(1):71-81. PubMed ID: 36620876
[TBL] [Abstract][Full Text] [Related]
23. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
[No Abstract] [Full Text] [Related]
24. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
25. 14-3-3σ downregulation sensitizes pancreatic cancer to carbon ions by suppressing the homologous recombination repair pathway.
Wang D; Luo H; Chen Y; Ou Y; Dong M; Chen J; Liu R; Wang X; Zhang Q
Aging (Albany NY); 2024 Jun; 16(11):9727-9752. PubMed ID: 38843383
[TBL] [Abstract][Full Text] [Related]
26. CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L.
Liu W; Hu D; Li J; Xu Q; Chen Z; Xu B
Cancer Biol Ther; 2023 Dec; 24(1):2216041. PubMed ID: 37287122
[TBL] [Abstract][Full Text] [Related]
27. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/AKT activation and tumorigenesis of pancreatic adenocarcinoma.
Xu Z; Liu Y; Pan Z; Qin L
Histol Histopathol; 2024 Feb; 39(2):263-277. PubMed ID: 37232506
[TBL] [Abstract][Full Text] [Related]
29. BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma.
Zhu Y; Zhang C; Zhao D; Li W; Zhao Z; Yao S; Zhao D
Dis Markers; 2021; 2021():7842035. PubMed ID: 34777634
[TBL] [Abstract][Full Text] [Related]
30. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
[TBL] [Abstract][Full Text] [Related]
31. CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression.
Zhang H; Yu H; Ren D; Sun Y; Guo F; Cai H; Zhou C; Zhou Y; Jin X; Wu H
Int J Biol Sci; 2022; 18(8):3484-3497. PubMed ID: 35637952
[TBL] [Abstract][Full Text] [Related]
32. Diverse CBX family members as potential prognostic biomarkers in non-small-cell lung cancer.
Xie X; Ning Y; Long J; Wang H; Chen X
FEBS Open Bio; 2020 Oct; 10(10):2206-2215. PubMed ID: 32894652
[TBL] [Abstract][Full Text] [Related]
33. High
Lv S; Zhang G; Xie L; Yan Z; Wang Q; Li Y; Zhang L; Han Y; Li H; Du Y; Yang Y; Guo X
Biomed Res Int; 2020; 2020():2585862. PubMed ID: 32185195
[TBL] [Abstract][Full Text] [Related]
34. Integrated analysis identified the role of three family members of ARHGAP in pancreatic adenocarcinoma.
Fei H; Shi X; Sun D; Yang H; Wang D; Li K; Si X; Hu W
Sci Rep; 2024 May; 14(1):11790. PubMed ID: 38783033
[TBL] [Abstract][Full Text] [Related]
35. CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma.
Zhou C; Wang L; Hu W; Tang L; Zhang P; Gao Y; Du J; Li Y; Wang Y
Bioengineered; 2022 May; 13(5):13089-13107. PubMed ID: 35615982
[TBL] [Abstract][Full Text] [Related]
36. PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
Xia W; Bai H; Deng Y; Yang Y
J Cell Mol Med; 2020 Nov; 24(21):12642-12655. PubMed ID: 32985124
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
Xu F; Zhang Z; Zhao Y; Zhou Y; Pei H; Bai L
Gene; 2021 Aug; 795():145804. PubMed ID: 34175402
[TBL] [Abstract][Full Text] [Related]
38. NDUFA4 promotes cell proliferation by enhancing oxidative phosphorylation in pancreatic adenocarcinoma.
Zhang Y; Ge M; Chen Y; Yang Y; Chen W; Wu D; Cai H; Chen X; Wu X
J Bioenerg Biomembr; 2022 Dec; 54(5-6):283-291. PubMed ID: 36307669
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma.
Luo L; Zhang G; Wu T; Wu G
Med Sci Monit; 2021 Nov; 27():e933443. PubMed ID: 34799547
[TBL] [Abstract][Full Text] [Related]
40. Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcinoma proliferation.
Qiao S; Wu F; Wang H
Cancer Rep (Hoboken); 2024 Jun; 7(6):e2108. PubMed ID: 38837874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
